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Introduction {#sec1}
============

The human brain comprises more than 300 neuronal cell types, with an undetermined number of subtypes. Their underlying developmental programs are mostly unknown. In recent years, miRNAs have been identified as an important part of neurogenesis ([@bib1]). miRNAs bind in a sequence-specific manner to mRNA transcripts and thereby negatively interfere with the simultaneous translation of multiple target transcripts by annealing predominantly at the 3′ untranslated region (UTR). miR-124 is one of the most abundant miRNAs in the brain and is associated with processes such as neurogenesis ([@bib36], [@bib38]), cancer ([@bib64], [@bib66]), and the control of synaptic functions in mature neurons in health ([@bib16], [@bib31], [@bib57]) and disease ([@bib19], [@bib45]) including cognitive impairment ([@bib21], [@bib72]).

It remains unclear if miR-124 is controlling the initiation of neuronal differentiation ([@bib2], [@bib8], [@bib11], [@bib13], [@bib46], [@bib69], [@bib74], [@bib75]) or the maturation and survival of the differentiated neurons ([@bib20], [@bib24], [@bib40], [@bib61], [@bib71], [@bib76]), or both. Knockdown studies using sponge approaches ([@bib2]) or antisense constructs ([@bib11], [@bib13]) resulted in decreased neurogenesis. However, transcriptomic alterations from knockdown approaches are mild and their interpretation difficult. Gain-of-function experiments resulted in elevated neuronal differentiation of mouse embryonic stem cells ([@bib35]), HeLa cells ([@bib41]), and glioblastoma cells ([@bib64]). Forced expression of miR-124 in combination with miR-9 converts human fibroblasts into neuronal cell types ([@bib75]), highlighting miR-124's cell fate-determining potency. Therefore, miR-124 was suggested to play a key role during neuronal differentiation by promoting the exit from the cell cycle, downregulating pro-proliferative genes, and activating neuron-specific genes ([@bib13], [@bib46], [@bib69]).

However, previous knockout studies in mouse models were incomplete as not all three miR-124 paralogs, six alleles in total, coding for identical mature miRNAs were ablated ([@bib61]). There is also a high heterogeneity of neuronal progenitor cells *in vivo*, impeding studies of miR-124 in defined cell types ([@bib73]). Pooling heterogeneous cell types that differ in their coding and non-coding transcriptome likely results in incomplete views on miR-124's complex regulatory role with 4,024 computationally predicted targets as well as additional potential non-canonical binding events ([@bib12], [@bib52]). So far, most studies have experimentally validated only a single or very few miR-124 targets at once. It remains unclear how many miR-124 targets are simultaneously regulated within a cell and what their orchestrated impact is---direct and also indirect---via gene regulatory cascades. Therefore, it is essential to investigate miR-124's functions in a well-defined, homogeneous, and complete knockout model to overcome the above-mentioned limitations.

We used a human induced pluripotent stem cell (hiPSC)-based model system to mimic neurogenesis of bipolar neurons under controlled and reproducible conditions ([@bib6]). By CRISPR/Cas9 genome editing ([@bib14], [@bib47]), a full miR-124 knockout of all six genomic copies was generated. By forced transcription factor (TF) induction, we rapidly and robustly induced neuronal differentiation in wild-type (WT) and ΔmiR-124 cells. Subsequently, we performed an in-depth molecular, cellular, and physiological characterization of the ΔmiR-124 and isogenic WT lines, which revealed altered morphological and functional features, different neurotransmitter specification, and decreased long-term viability. We performed RNA-interacting protein immunoprecipitation (IP) and subsequent sequencing (RIP-seq) ([@bib48], [@bib56]) to capture active miRNAs and their mRNA targets bound to Argonaute-2 (AGO2), identifying 98 miR-124-regulated targets in parallel.

Cross-correlating RIP-seq experiments, miRNA quantifications, and time course RNA sequencing (RNA-seq) enabled us to identify other miRNA species with increased activity upon miR-124 deletion. Since we were mainly interested in functional differences between TF networks in WT and ΔmiR-124 neurons, we applied an advanced weighted topological overlap (wTO) network analysis ([@bib5], [@bib53]), followed by a co-expression differential network analysis ([@bib28]). Using this computational approach, we were able to detect similarities and specific differences in WT and ΔmiR-124 neurogenesis at the level of genes and their regulatory connections, including the impacts on neurogenesis of the uncharacterized TF *ZNF787*. Our results highlight the complexity of the downstream effects of experimental miRNA manipulations.

Results {#sec2}
=======

Generation of a Human iPSC-Based miRNA-124 Knockout Model {#sec2.1}
---------------------------------------------------------

We wanted to study miR-124 functions with an emphasis on neurogenesis in a robust, well-defined, and inducible neuronal cell line derived from hiPSCs in which miR-124 is highly expressed ([@bib6]). This so-called inducible-neurogenin cell line (iNGN) consists of stably integrated expression cassettes coding for the reverse tetracycline-controlled transactivator 3 (rtTA3) and the TFs neurogenin-1 and -2 (Neurog1/2), which are driven from the doxycycline-inducible promoter ([Figure 1](#fig1){ref-type="fig"}A). Hence, iNGN cells are hiPSCs, in which doxycycline administration triggers neurogenesis into a homogenous population of bipolar-shaped neurons within 4 days post induction (dpi), which can be cultured for months and acquire robust functional properties ([@bib37]).Figure 1Generation of an miR-124 Knockout Stem Cell Line(A) Schematic illustration of the inducible neurogenin-1/2 (iNGN) stem-cell line in which neurogenesis from hiPSCs to post-mitotic neurons can be triggered within 4 days.(B) CRISPR-Cas9 miR-124 depletion strategy. All three miR-124 loci were targeted by four specific 5′- and 3′-flanking gRNAs as indicated by differently colored triangles.(C) Sanger sequencing results of miR-124 genomic loci. All six alleles were disrupted.(D) qRT-PCR analysis indicated the lack of miR-124 expression in ΔmiR-124 cells, tested in iPSCs (0 dpi) and neurons (4 dpi). Statistical analysis was performed using unpaired Student's t tests with ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01. Data are represented as mean ± SEM.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To completely delete miR-124 in iNGN cells, we applied the CRISPR/Cas9 technology ([@bib58]) to knock out all three genomic loci, six alleles in total, which encode for the identical mature miR-124 sequence. We designed four unique gRNAs, which in pairs flanked all miR-124 loci ([Figure 1](#fig1){ref-type="fig"}B; [STAR Methods](#sec4){ref-type="sec"}). Transient expression of the Cas9 protein and gRNA pairs in uninduced iNGN cells resulted in complete genomic deletions of all miR-124 loci ([Figure 1](#fig1){ref-type="fig"}C). We thoroughly compared a monoclonal homogeneous ΔmiR-124 line with an isogenic monoclonal iNGN control (WT) and detected no off-target effects in top-predicted genomic sites by sequencing or chromosomal alterations when karyotyping in the ΔmiR-124 cell line ([Figure S1](#mmc1){ref-type="supplementary-material"}; [STAR Methods](#sec4){ref-type="sec"}). We observed miR-124 expression neither in the ΔmiR-124 line as iPSCs (0 dpi) nor in neurons at 4 dpi ([Figure 1](#fig1){ref-type="fig"}D), whereas in WT we measured an 18-fold increase in miR-124 expression: this demonstrates the successful generation of a complete miR-124 knockout cell line.

miR-124 Loss Leads to Molecular and Phenotypic Changes in Induced Neurons {#sec2.2}
-------------------------------------------------------------------------

We then characterized the effects of miR-124 deletion on neurogenesis by inducing neuronal differentiation in ΔmiR-124 and WT cells. In both lines, we detected specific neuronal markers such as MAP2, TUBB3, DCX, NEUN, and NCAM1 using immunocytochemistry at 4 dpi, indicating the presence of neurons ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A). Next, we quantified representative protein levels of pluripotency and neuronal lineage commitment by flow cytometry. In both cell lines, the TRA-1-60 signal, a marker for pluripotency, decreased, whereas the NCAM1 signal, a neuronal marker, increased during the course of differentiation. In ΔmiR-124 cells, signals for TRA-1-60 (p \< 0.01 for 2 dpi and 3 dpi) and NCAM1 (p \< 0.05 for 1 dpi, 2 dpi, and 3 dpi) were significantly lower ([Figure 2](#fig2){ref-type="fig"}B). Still, the ΔmiR-124 cells clearly differentiated into neurons after induction of neurogenesis, suggesting that neurogenesis in iNGN cells was independent of miR-124.Figure 2Phenotypic Characterization of ΔmiR-124 versus WT Cells(A) Immunostainings of indicated neuronal markers at 4 dpi and 0 dpi (hiPSC control).(B) Loss of pluripotency (TRA-1-60) and neural lineage commitment (NCAM1) 0--4 dpi measured by flow cytometry using the surface markers indicated.(C) Representative images of WT and ΔmiR-124 neurons at 4 dpi with differing morphology.(D) Quantification of bipolar morphology for WT and ΔmiR-124 neurons at 4 dpi. n, number of independent samples.(E) Quantification of neurite outgrowth velocities of WT and ΔmiR-124 neurons. n, number of neurites measured.(F) Quantification of bipolarity of ΔmiR-124 with and without miR-124 overexpression at 4 dpi. The overexpression of miR-124 rescued the typical bipolar morphology (see also [STAR Methods](#sec4){ref-type="sec"}). n, number of independent samples.(G) Quantification of neurite outgrowth velocities of ΔmiR-124 neurons at 5 dpi with and without miR-124 overexpression. The impairment was rescued by miR-124 overexpression. n, number of neurites measured.(H) Example traces and action potential (AP) quantification for 7 and 14 dpi of WT and ΔmiR-124. APs were induced by current injection.(I) Quantification of cell capacitance of WT and ΔmiR-124 neurons at 7 and 14 dpi, indicating similar cell sizes for each time point.(J) Quantification of membrane voltage of WT and ΔmiR-124 at 7 and 14 dpi, an indicator for potassium and proton channel activity.(K--M) Quantification of peak and steady currents with example traces (K) at 7 and 14 dpi. Peak currents are sodium-channel dominated, whereas steady currents are potassium-channel dominated.Scale bars, 100 μm. Sample number, n, refers to the number of biological samples (B, D, and F), number of analyzed neurites (E and G), and number of recorded cells as stated in (H) (H--M). Statistical analysis, unpaired Student's t tests for two-group comparisons and Holm-Sidak correction for multiple comparisons with ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001. Data are represented as mean ± SEM.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Microscopic analysis revealed that fewer ΔmiR-124 cells became bipolar-shaped (i.e., normal WT morphology): the bipolar neuronal fraction significantly decreased from 96.6% ± 0.3% in WT to 71.3% ± 4.3% (p \< 0.05) in ΔmiR-124 neurons, with many ΔmiR-124 cells showing a more complex morphology at 4 dpi ([Figures 2](#fig2){ref-type="fig"}C and 2D). We analyzed neurite outgrowth, which can correlate with differences in morphology, by time-lapse microscopy: the outgrowth velocity was significantly reduced (p \< 0.05) to 0.66 ± 0.13 μm/min in ΔmiR-124 neurons compared to 1.02 ± 0.11 in WT ([Figures 2](#fig2){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}E), whereas overexpressing (OE) miR-124 in ΔmiR-124 neurons reset the morphology to 97.6% ± 0.8% bipolar shape (p \< 0.001; [Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}B--S2D). In addition, we found neurite outgrowth velocities comparable to WT levels in miR-124 supplemented ΔmiR-124 cells (from 0.37 ± 0.11 μm/min to 1.11 ± 0.12 μm/min; p \< 0.001; [Figures 2](#fig2){ref-type="fig"}G and [S2](#mmc1){ref-type="supplementary-material"}F). Our data suggest that miR-124 deletion led to phenotypic differences, which were reversible. Thus, miR-124 was dispensable for the general neuronal differentiation program in WT and ΔmiR-124 iNGN cells but resulted in an increased and reversible morphological heterogeneity. We confirmed that neurogenesis was independent of the miR-124 knockout clone ([Figure S2](#mmc1){ref-type="supplementary-material"}M), the underlying hiPSC line ([Figures S2](#mmc1){ref-type="supplementary-material"}K--S2N), and the TF-overexpression neuronal induction protocol, since an alternative small molecule-based induction resulted in neurons with equal efficiency within 21 dpi ([Figures S2](#mmc1){ref-type="supplementary-material"}H--S2J) ([@bib60]).

ΔmiR-124 Neurons Become Electrophysiologically Active {#sec2.3}
-----------------------------------------------------

As general neurogenesis was unaffected, we questioned whether ΔmiR-124 iPSCs undergo functional neuronal maturation. We tested the electrophysiological properties of WT and ΔmiR-124 neurons and found that all WT cells (n = 12) fired action potentials (APs) and that one fired multiple APs upon current injection at 7 dpi ([Figure 2](#fig2){ref-type="fig"}H). At 14 dpi, 92% (n = 13) of WT cells generated APs, with 31% AP firing trains. ΔmiR-124 cells generated APs as well: 92% (n = 13) at 7 and 14 dpi, with one cell firing multiple APs at 14 dpi. Both cell lines showed similar capacitance and membrane potential, suggesting similar cell sizes and passive conductive properties ([Figures 2](#fig2){ref-type="fig"}I and 2J). However, ΔmiR-124 cells were characterized by a lower voltage-dependent peak current in a voltage range from −30 mV to +10 mV at 14 dpi (p \< 0.05; [Figures 3](#fig3){ref-type="fig"}K--3M) but showed similar steady currents ([Figures 2](#fig2){ref-type="fig"}L and 2M) compared to WT cells. This peak current shift in ΔmiR-124 neurons ([Figures 2](#fig2){ref-type="fig"}L and 2M) indicated reduced sodium channel expression levels or altered channel properties. In summary, our data suggest that both WT and ΔmiR-124 neurons became functional, although with differences in specific properties, suggesting that miR-124 has only a minor impact on neuronal maturation.Figure 3Transcriptomic Characterization of WT and ΔmiR-124 Neurons(A) Heatmap of differentially expressed genes (RNA-seq, z scores, n = 7 biological replicates) for WT and ΔmiR-124 cells for selected neuronal and pluripotency markers over the time course of differentiation. Asterisks mark significant differences between the cell lines (^∗^p~adj~ \< 0.05 and fold difference ≥ 1.5).(B) Principal-component analysis showing the greatest variance dimensions of time course expression data from WT and ΔmiR-124 cells.(C) Correlation analysis of WT and ΔmiR-124 neurons to the developing human brain. Pearson correlation of the 1,000 most differentially expressed genes compared to the transcriptomic Allen BrainSpan Atlas dataset for the developmental stages from 8 to 37 postconceptional weeks (pcw). Abbreviations represent brain regions: AM, amygdaloid complex; CC, cerebellar cortex; ST, striatum; HC, hippocampus.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.(D) Graphical illustration of the Allen BrainSpan Atlas analysis (C) for WT neurons at 4 dpi.(E) Graphical illustration of the Allen BrainSpan Atlas analysis (C) for ΔmiR-124 neurons at 4 dpi.

Transcriptomic Differences in WT and ΔmiR-124 Neuronal Populations {#sec2.4}
------------------------------------------------------------------

In order to assess how the phenotypic differences were reflected at the transcriptomic level, we used RNA-seq to assess transcriptomic profiles of ΔmiR-124 and WT cells over the course of neuronal differentiation between 0 dpi and 4 dpi (n = 7 biological replicates for each cell line per time point). In line with our immunohistochemical analysis, key neuronal markers (*MAP2*, *TUBB3*, *PAX6*, *SOX1*, and *RBFOX3*) were expressed in ΔmiR-124, with small but significantly altered levels (p~adj~ \< 0.05 and \>1.5-fold) compared to WT ([Figure 3](#fig3){ref-type="fig"}A). As expected, pluripotency genes decreased over 4 days. Sodium channels were significantly decreased (p~adj~ \< 0.05 and \>1.5-fold) (*SCN2A*/NaV1.2) or unchanged (*SCN8A*/NaV1.6), which may explain the differences in peak currents ([Figure 2](#fig2){ref-type="fig"}M). WT iNGN neurons have previously been characterized as co-transmitting glutamate and acetylcholine as both neurotransmitter synthesis and secretion pathways are upregulated at 4 dpi ([@bib6]). Here, subtype-specific markers differed significantly (p~adj~ \< 0.05 and \>1.5-fold) from a glutamatergic specification (*VGLU1/VGLU2/NMDA1*) in WT to cholinergic in ΔmiR-124 cells (*CHAT*; [Figure 3](#fig3){ref-type="fig"}A).

We studied the overall changes in gene expression in the absence of miR-124 by analyzing differential gene expression patterns between WT and ΔmiR-124 over the course of neurogenesis ([Figure S3](#mmc1){ref-type="supplementary-material"}A). We found 2,884 genes to be differentially expressed at 0 dpi, 10,820 at 1 dpi, 10,897 at 2 dpi, 15,196 at 3 dpi, and 15,731 at 4 dpi (p~adj~ \< 0.05; [Figure S3](#mmc1){ref-type="supplementary-material"}A). These genes were involved in differentiation, cell adhesion, morphogenesis, and cell division.

Next, we analyzed the transcriptional differentiation course of WT and ΔmiR-124 cells using a principal-component analysis (PCA) of RNA-seq data (n = 7) ([Figure 3](#fig3){ref-type="fig"}B). Comparing the greatest variance dimensions, individual replicates showed minimal variance per time point. At 0 dpi, WT and ΔmiR-124 samples clustered together, suggesting that both cell lines started from a similar cellular ground state. From 1 dpi on, WT and ΔmiR-124 samples diverged and took different paths during differentiation. There was no common endpoint convergence at 4 dpi, suggesting the presence of two distinct populations.

Using their transcriptomic profiles, we categorized WT and ΔmiR-124 cells from different brain regions and developmental stages. The expression profiles of 4 dpi WT and ΔmiR-124 neurons were separately correlated with the Allen BrainSpan Atlas dataset, which includes RNA-seq data from mixed cell populations acquired from 16 brain structures between 8 post-conception weeks (pcw) and 40 years of age ([@bib50]). We detected the highest correlation coefficients (Pearson correlations \> 0.3) between 8 and 37 pcw, suggesting that WT and ΔmiR-124 neurons most closely represented prenatal neurons ([Figures 3](#fig3){ref-type="fig"}C--3E; [STAR Methods](#sec4){ref-type="sec"}). Focusing on spatial information, WT neurons correlated best with expression data from the amygdaloid complex, cerebellar cortex, and hippocampus, while ΔmiR-124 neurons were most similar to the cerebellar cortex, hippocampus, and striatum (Pearson correlations \> 0.39) ([Figures 3](#fig3){ref-type="fig"}D and 3E). The differences between WT and ΔmiR-124 neurons were also detected at later time points (7 dpi and 14 dpi, n = 3 biological replicates for each cell line per time point). WT samples correlated also to prenatal cortical areas ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C) and had higher correlation scores, suggesting that these neurons are more likely to be found in the human brain.

AGO2 Complex Precipitation Identifies Active miRNA-mRNA Pairs {#sec2.5}
-------------------------------------------------------------

How is miR-124 linked to the aforementioned morphological and functional differences between WT and ΔmiR-124 cells? As miRNAs repress gene expression, we expected direct miR-124 targets to be upregulated after miR-124 deletion. Computational predictions of miRNA target genes necessarily remain inconclusive because one miRNA can bind to thousands of targets and most mRNAs have multiple miRNA binding sites. There are 4,024 annotated human transcripts with miR-124 binding sites (according to miRWalk with RNA22, Targetscan, and miRanda databases) ([@bib17], [@bib34], [@bib39], [@bib51]). Furthermore, the impact of miRNAs on target gene repression has been found to be mostly moderate ([@bib3], [@bib26]). Just focusing on mRNA expression data may most likely be insufficient for a systematic assessment of biologically active miR-124 targets as it would also deliver many secondary and therefore indirect targets. Thus, we used AGO2-RIP-seq to identify active miRNAs and their targets in parallel. The physical binding of miRNA to their mRNA targets occurs in the RNA-induced silencing complex (RISC), in which AGO2 is one of the central enzymes ([@bib43]). IP of AGO2 includes bound miRNA and mRNA molecules that can be identified by subsequent RNA-seq: we performed this for both AGO2-IP and whole-cell samples (pre-IP whole-cell RNA samples). We then conducted a differential AGO2-precipitated concomitance analysis of mRNA and miRNA molecules from WT and ΔmiR-124 samples. Subsequently, we filtered for active miR-124 targets ([Figure 4](#fig4){ref-type="fig"}A). For quality control, we checked for equal amounts of AGO2 protein levels between samples ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B) and a decrease in mitochondrial mRNAs after IP ([Figure S4](#mmc1){ref-type="supplementary-material"}C): these were expected as mitochondrial RNA is not bound to the RISC. Furthermore, miRNA, snoRNA, and snRNA levels were equal between WT and ΔmiR-124 in whole-cell samples ([Figure S4](#mmc1){ref-type="supplementary-material"}D).Figure 4Parallel Identification of miR-124 Targets by AGO2-RIP-Seq Analysis(A) Schematic representation of the AGO2-RIP-seq experiment using AGO2 precipitation and subsequent sequencing of mRNAs and miRNAs to identify active pairs.(B) Differentially expressed genes were filtered as shown in the Venn diagram. Transcripts with less 3′ UTR signal in AGO2-IP data in ΔmiR-124 samples were intersected with significantly upregulated transcripts in the whole-cell samples. 127 transcripts overlapped, of which 98 were annotated miR-124 targets.(C) 98 high-probability miR-124 targets filtered for 3′ UTR peak signal decrease (left) and increase in expression (right). Data are presented as mean ± log~2~-fold change standard error (lfcSE). Experimentally validated targets according to miRTarBase are indicated in red. 43 additional targets were validated by luciferase reporter assays; color code indicates relative luciferase signal reduction upon miR-124 overexpression.(D) Venn diagram showing miRTarBase entries intersected with the 98 filtered miR-124 targets.(E) Pie chart, summarizing previous (miRTarBase), experimentally validated (luciferase reporter assays) and untested miR-124 targets.(F) GO term enrichment analysis of filtered miR-124 targets indicating their involvement in apoptosis and synaptic maturation.(G) Assessment of cell viability from 0 to 14 dpi. The percentage of live cells was measured using the ApoToxGlo assay. The ratio between fluorescence signal for live cells (AFC) and total cell fluorescence (AFC + R110) was examined and normalized to 100% for 0 dpi.(H) Assessment of apoptosis from 0 to 14 dpi. Luciferase activity corresponding to Caspase 3/7 activity was measured using the ApoToxGlo assay. Luciferase activity was normalized to the live cell fluorescence (AFC).Statistical analysis, unpaired Student's t tests with Holm-Sidak correction for multiple comparisons with ^∗^p ≤ 0.05, ^∗∗∗^p ≤ 0.001. Data are represented as mean ± SEM.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Reads from AGO2-RIP-seq were mapped to the reference genome, and regions surpassing a read threshold (see [STAR Methods](#sec4){ref-type="sec"}) were considered as peaks. Peaks specific to WT samples were filtered out of the WT and ΔmiR-124 datasets. We used transcript expression levels from whole-cell samples to normalize RIP-seq signals ([@bib62]; see [STAR Methods](#sec4){ref-type="sec"}). 2,338 genes had significant peak region signals in the WT but not in the ΔmiR-124 samples. We also analyzed for differential gene expression, finding 1,909 genes with significantly increased expression levels in WT compared to ΔmiR-124 cells (p~adj~ \< 0.05; [Figure 4](#fig4){ref-type="fig"}B). The AGO2-RIP-seq signals did not recapitulate the distribution of WT and ΔmiR-124 whole cell RNA-seq samples, suggesting a different RISC-complex occupation of available mRNAs ([Figure S4](#mmc1){ref-type="supplementary-material"}F). By intersecting these genes, we identified 127 transcripts with reduced 3′ UTR peaks (AGO2 IP) and increased expression in whole-cell ΔmiR-124 samples, of which 98 (77.2%) were predicted to be miR-124 targets ([Figures 4](#fig4){ref-type="fig"}B and 4C). 38 of the 98 targets had previously been validated ([Figure 4](#fig4){ref-type="fig"}C; taken from miRTarBase; marked in red) ([@bib33]). We used luciferase reporter assays to further test 45 3′ UTRs, confirming that 43 filtered targets were indeed miR-124 targets ([Figures 4](#fig4){ref-type="fig"}D and 4E). In summary, the AGO2-RIP-seq analysis enabled a comprehensive parallel identification of 98 high-confidence active miR-124-targets (81/98 validated) from the 4,024 annotated targets in iNGN neurons ([Figure 4](#fig4){ref-type="fig"}E). However, this number most likely underestimated the complete target repertoire, as our filters were quite stringent and we did not capture any targets that were only regulated at the protein level.

Increased miR-124 Target Expression Leads to Decreased Neuronal Viability {#sec2.6}
-------------------------------------------------------------------------

We further analyzed the 98 high-probability targets to assess their involvement in biological processes using a Gene Ontology (GO) term analysis ([Figure 4](#fig4){ref-type="fig"}F). We detected that terms associated with synaptic maturation and apoptosis were enriched among those target genes at 4 dpi ([Figure 4](#fig4){ref-type="fig"}F). As ΔmiR-124 cells became electrically active over time but had significantly increased transcriptomic traces of apoptosis, we experimentally investigated cell viability and apoptosis rates (caspase 3/7 activity) ([@bib70]) in WT and ΔmiR-124 neurons over 14 days in culture ([Figures 4](#fig4){ref-type="fig"}G and 4H). ΔmiR-124 cell viability was significantly decreased from 4 dpi onward (p \< 0.05), and caspase 3/7 activity was significantly enhanced (p \< 0.05) in ΔmiR-124 compared to WT. The viability of ΔmiR-124 cells over time was significantly increased by miR-124 supplementation (p \< 0.05; [Figure S4](#mmc1){ref-type="supplementary-material"}E), suggesting that miR-124 expression is directly linked to neuronal survival. The 98 identified miR-124 targets remained increased in expression at 7 and 14 dpi ([Figure S4](#mmc1){ref-type="supplementary-material"}F), and the associated GO terms further supported miR-124's impact on neuronal survival, specification, and maturation ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E).

miRNA Transcriptome Dynamics upon miR-124 Depletion {#sec2.7}
---------------------------------------------------

We next investigated how the global miRNA expression profile reacted to the depletion of a highly abundant miRNA species such as miR-124. Previously, we had found that miR-124 represented about 80% of the miRNA profile in iNGN cells at 4 dpi ([@bib6]). It has also been shown that a full miRNA depletion, by knocking out key enzymes of the miRNA processing machinery, can lead to downregulation of RISC protein members, including AGO2 protein levels ([@bib7], [@bib49]). This results in an overall decrease in miRNA-mediated regulation. Therefore, we analyzed whether the deletion of miR-124 in iNGN cells also resulted in an overall decrease in the miRNA machinery. However, we did not detect any significant decreases in AGO2 protein levels ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Therefore, miRNAs were likely still able to exert their functions. In addition, we performed nCounter miRNA quantifications of WT and ΔmiR-124 samples at 0 dpi and 4 dpi (n = 3 replicates per sample and time point) and found similar count distributions at 0 dpi ([Figure 5](#fig5){ref-type="fig"}A). However, at 4 dpi, we detected a shift toward higher counts in ΔmiR-124 samples, suggesting that other miRNAs in ΔmiR-124 neurons were increased in numbers ([Figure 5](#fig5){ref-type="fig"}B).Figure 5Dynamic Co-regulatory Effects of Other miRNAs in the Absence of miR-124(A and B) Density plots of normalized nCounter counts for WT and ΔmiR-124 at 0 dpi (A) and 4 dpi (B).(C) Significant differentially expressed miRNAs from sRNA-seq with nCounter \> 200 counts.(D) Venn diagram of highly abundant miRNAs (nCounter \> 200 counts) that were upregulated in ΔmiR-124 and showed higher AGO2 signals in ΔmiR-124 compared to WT.(E) Increased AGO2-RIP signals and decreased log~2~-fold changes for miRNA targets shown in (D) that were previously validated (miRTarBase). Data are represented as mean ± SEM.

Next, we looked at miRNAs that were differentially expressed in AGO2-RIP-seq samples. As expected, we found miR-124 to be significantly downregulated at 4 dpi ([Figure S5](#mmc1){ref-type="supplementary-material"}A). We put an emphasis on upregulated miRNA species as these molecules likely took over miRNA regulatory functions in ΔmiR-124 cells ([Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}A). As amplification biases occur massively during small RNA-seq (sRNA-seq) library preparation ([@bib29], [@bib42], [@bib67]), we aimed at combining our differential expression analysis of AGO2-RIP-seq and sRNA-seq data with nCounter quantifications to filter for both upregulated and sufficiently expressed miRNAs that took over regulatory functions in the absence of miR-124. Eight miRNA species had increased levels in AGO2-RIP-seq and whole cell sRNA-seq ΔmiR-124 samples compared to WT and more than 200 nCounter counts at 4 dpi ([Figure 5](#fig5){ref-type="fig"}D). Furthermore, these miRNAs showed enhanced association in the AGO2 complex by normalizing to whole-cell signals and activity ranking within the AGO2 complex ([Figure S5](#mmc1){ref-type="supplementary-material"}B; [STAR Methods](#sec4){ref-type="sec"}). Differences in miRNA expression ranking between WT and ΔmiR-124 samples suggested new biologically active miRNA regulations within the RISC in the absence of miR-124. We looked for validated targets of these eight miRNAs and highlighted 12 genes with increased peak signal differences (AGO2-RIP-seq) and significantly decreased expression levels in whole cell samples in ΔmiR-124 samples compared to WT. Our data indicated that these genes became regulated by other miRNAs in the absence of miR-124. Performing a GO term analysis on their validated targets (miRTarBase) further suggested involvement in neuronal morphology ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

Taken together, we revealed that the depletion of miR-124 resulted in dynamic changes of actively expressed miRNAs taking over regulatory actions on their corresponding target repertoire, resulting in indirect effects on the coding and non-coding transcriptome during neurogenesis.

A Network of Transcription Factors Is Influenced by miR-124 {#sec2.8}
-----------------------------------------------------------

A significant fraction of the identified miR-124 targets (24/98, p \< 0.05; χ^2^ test) coded for TFs, suggesting that miRNA-124 exerts much of its impact via influencing gene regulatory cascades involving many TFs. Measuring indirect miRNA effects is not trivial ([@bib30]) but essential to understanding the full spectrum of miRNA regulation. We conducted a time-lapse network analysis focusing on the 24 miR-124 targets coding for TFs to understand the miR-124 regulatory network underlying neurogenesis.

For each time point and, separately, for WT and ΔmiR-124 cells (n = 7 for each time point), we identified genes that correlated with the 24 TFs. Correlated genes represent potential target genes or interaction partners of TFs. To reveal how similar TFs were to their correlated target genes, we calculated wTO networks for all expressed TFs for each time point for WT and ΔmiR-124 cells separately ([Figures 6](#fig6){ref-type="fig"}A, [S6](#mmc1){ref-type="supplementary-material"}A, [S7](#mmc1){ref-type="supplementary-material"}A, and S7B). Nodes in these wTO networks represent TFs, and they are connected by a link if they share a significant number of correlated genes, that is, are likely acting together in regulating their target genes. One advantage of wTO networks is that they result in more robust definitions of connections and interactions among genes than simple correlation networks because they suppress false positive inferences ([@bib9], [@bib27], [@bib53], [@bib59]). In contrast to the widely used weighted gene co-expression network analysis (WGCNA) ([@bib77]), the wTO network that we have developed accommodates both positive and negative correlations, which are essential for analyzing TFs as they have both enhancing and repressing functions ([@bib27], [@bib53]). Furthermore, our method also assigns p values to each link, resulting in a high-accuracy network based on seven replicates, which is important for comparing networks with high confidence ([@bib27]). At 0 dpi, WT and ΔmiR-124 networks were identical. They started to differ from 1 dpi, peaked in differences at 3 dpi ([Figure 6](#fig6){ref-type="fig"}A), and decreased in differences at 4 dpi ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). To reveal the contrast between the WT and ΔmiR-124 networks, we subtracted the wTO of ΔmiR-124 from the wTO of WT, resulting in differential networks ([Figures 6](#fig6){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}A, top). In WT cells, a number of links were reactivated at different time points, while in the ΔmiR-124 cells most links were unique, suggesting the presence of different regulatory modes and global changes after miR-124 loss ([Figure S7](#mmc1){ref-type="supplementary-material"}C). We classified the differentially expressed TFs (14.95%, n = 3,145) using a self-organizing map (SOM) algorithm ([Figures 6](#fig6){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}D). The SOM categories with a steady increase in differential expression over time were considered to be the best candidates for also being influenced by miR-124, as they were expected to be upregulated in the absence of the negative regulator ([Figures 6](#fig6){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}D). Most miR-124 targets obtained from RIP-seq filtering ([Figures 4](#fig4){ref-type="fig"}A--4C) appeared in the monotonically increasing SOM categories, which is in line with the lack of repressing miR-124 ([Figures 4](#fig4){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}D): the targets previously described included *PTBP1*, which was identified as an important factor within our co-expression network ([Figure 6](#fig6){ref-type="fig"}A). Nodes including *GLIS2*, *SERTAD3*, and *TP73* appeared to be very important as these genes fulfilled all criteria: they were filtered and validated targets ([Figure 4](#fig4){ref-type="fig"}C), were top hits in the network analysis, and followed a rising trend in the SOM clustering.Figure 6Target-TF-Network Analysis Indicates Indirect---TF-Mediated---miR-124 Regulatory Actions(A) Expression correlation as weighted topological overlap (wTO) between TFs that were differentially expressed at 3 dpi. Every panel shows the network at 3dpi for WT (middle), ΔmiR-124 (bottom), and the difference (top). The opacity of the lines indicates the wTO value of that link. Colored gene names represent a specific SOM cluster as shown in [Figure 6](#fig6){ref-type="fig"}B. Underlined TFs are filtered miR-124 targets ([Figures 4](#fig4){ref-type="fig"}B and 4C).(B) Loess regression from self-organizing maps calculated on the basis of normalized fold changes of permanently (1 dpi--4 dpi) differentially expressed TFs. Color code represents the SOM clusters. Only four categories are shown (See also [Figure S7](#mmc1){ref-type="supplementary-material"}D).(C) Illustration of a miR-124 target-specific wTO subnetwork showing TF nodes at 3 dpi. Colored lines indicate negative or positive correlations of underlying associated genes.(D) Illustration of the subnetwork shown in (C), including underlying associated genes.(E) Quantification of *ZNF787* overexpression (OE) efficiency in WT neurons over time. n = 3 biological replicates. Significance was assessed with unpaired Student's t tests with Holm-Sidak correction for multiple comparisons with ^∗∗∗^p ≤ 0.001. Data are represented as mean ± SEM.(F) Representative immunostainings for DAPI and the neuronal marker MAP2. Scale bar, 50 μm.(G) GO term enrichment analysis of significantly downregulated transcripts (p~adj~ \< 0.05, log~2~-fold change \< \[−1\]) upon *ZNF787* overexpression indicating its impact on repressing neuronal differentiation and maturation.(H) Heatmap of *ZNF787*-associated genes reappearing in target-wTO networks for WT, ΔmiR-124, and WT-ZNF787-OE (RNA-seq, z scores from rlog-transformed counts, n = 3 biological replicates). Arrows indicate similar expression trends for ΔmiR-124 versus WT and WT-ZNF787 overexpression versus WT.See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

We focused specifically on 3 dpi, as we detected most network activity at this time point ([Figures 6](#fig6){ref-type="fig"}A, [S7](#mmc1){ref-type="supplementary-material"}C, and S7D). We also found some miR-124 targeted TFs with unknown functions (*ZNF787*) as well as human-specific indirectly targeted ones (*ZNF138*) within the dense 3 dpi network of the ΔmiR-124 samples (according to Uniprot; [@bib54]). Exemplarily, individual nodes around the miR-124 target *ZNF787* and connected *ZNF138* ([Figure 6](#fig6){ref-type="fig"}C) as well as their associated genes ([Figure 6](#fig6){ref-type="fig"}D) were extracted from our wTO analysis. This visualization emphasizes how embedded *ZNF787* was within the gene regulatory network upon miR-124 deletion at 3 dpi. Next, we aimed at perturbing the *ZNF787* node by OE *ZNF787* robustly in WT iNGN cells ([Figure 6](#fig6){ref-type="fig"}E). WT-ZNF787-OE cells underwent neurogenesis and were positive for the neuronal marker MAP2 ([Figure 6](#fig6){ref-type="fig"}F). We performed GO term analyses on differentially expressed genes between WT and WT-ZNF787 OE (n = 3 biological replicates, 4 dpi). Specifically, focusing on downregulated genes, many neuronal biological processes were significantly inhibited ([Figure 6](#fig6){ref-type="fig"}G). Hence, our data indicated that *ZNF787* represents a neuronal feature repressor. Looking at *ZNF787-*associated genes derived from our wTO analysis, corresponding expression levels massively differed between WT, ΔmiR-124, and WT-ZNF787-OE ([Figure 6](#fig6){ref-type="fig"}H). In particular, 51 out of 78 ZNF787-associated genes showed a similar expression trend for ΔmiR-124 and WT-ZNF787-OE in comparison to WT (Spearman correlation, R = 0.498 with p \< 0.001; Pearson correlation, R = 0.277 with p = 0.01). This further highlights ZNF787's impact on the gene regulatory network when its expression was increased due to miR-124 deletion or when overexpressed. However, ZNF787's overexpression did not hamper neurogenesis *per se* as the cells were still positive for MAP2 ([Figure 6](#fig6){ref-type="fig"}F).

In summary, our wTO analysis suggested that the TF networks were globally altered and differentially connected, especially at 3 dpi upon miR-124 depletion. In addition, our analysis identified uncharacterized TFs---of which *ZNF787* was experimentally validated---having regulatory functions during neurogenesis.

GO Term Analysis of wTO Network Nodes Reveals Indirect miR-124 Functions {#sec2.9}
------------------------------------------------------------------------

We next investigated which biological functions were controlled by the TF networks of WT and ΔmiR-124 cells at each time point, especially which functions were common or different between the networks. To this end, we used our co-expression differential network analysis tool ([@bib28]) and classified each correlation into common or specific connections ([Figures 7](#fig7){ref-type="fig"}A--7C and [S6](#mmc1){ref-type="supplementary-material"}B). Subsequently, we performed GO enrichment tests for these categories to reveal the biological processes the underlying genes were involved in.Figure 7Semantic Clustering of GO Terms Reveals Shared and Different Biological Processes at 3 dpi in WT and ΔmiR-124 Cells(A--C) Co-expression differential network analysis of shared (A), WT-specific (B), or ΔmiR-124-specific (C) regulated genes at 3 dpi. Underlying biological processes are grouped and highlighted. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

GO groups that were common between the WT and ΔmiR-124 networks at 0 dpi included, for example, "mRNA processing," "cell division," and "mitotic cell cycle" ([Figure 7](#fig7){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}). In particular, WT and ΔmiR-124 networks shared the groups "regulation of asymmetric cell division" and "regulation of extracellular matrix disassembly" at 1 dpi and "synapse assembly," "regulation of synapse organization," and "positive regulation of neurological system process" at 4 dpi, indicating that aspects of neurogenesis were also present in ΔmiR-124 cells.

However, we also found groups that were specific to the WT network. For example, the GO terms "layer formation in cerebral cortex" and "pyramidal neuron development" at 1 dpi, "regulation of exit from mitosis" and "positive regulation of long-term neuronal synaptic plasticity" at 2 dpi, "positive regulation of dendritic cell differentiation" at 3 dpi, and several "mRNA processing" groups at 4 dpi were different ([Table S1](#mmc2){ref-type="supplementary-material"}). Many metabolic terms and cell signaling pathways (Wnt signaling at 3 dpi) were also specific to WT cells ([Figure 7](#fig7){ref-type="fig"}B). This indicates that particular functions related to cell-cycle control and neuronal differentiation started to be differentially controlled in WT and ΔmiR-124 cells right from the beginning of neurogenesis.

ΔmiR-124 groups differed in ion incorporation and diverse metabolic processes at 1 and 2 dpi and "signal transduction resulting in induction of apoptosis," "positive regulation of long-term neuronal synaptic plasticity," "regulation of dendritic spine morphogenesis," and "striatal medium spiny neuron differentiation" at 3 dpi ([Figure 7](#fig7){ref-type="fig"}C). In contrast to Wnt signaling in WT, we detected phosphatidylinositol 3-kinase signaling in ΔmiR-124 groups. In particular, the GO term "striatal medium spiny neuron differentiation" was in line with the BrainSpan analysis ([Figures 3](#fig3){ref-type="fig"}C--3E). Our analysis further suggested that the differences in cell fate regulation were mediated by the altered miR-124-dysregulated TF networks in ΔmiR-124 cells at 3 dpi.

Our regulatory network analysis of the TFs, which are direct miR-124 targets, revealed clear differences in network architecture between WT and ΔmiR-124 samples: these increased until the cells become post-mitotic. These complex relationships, that is, indirect miR-124 functions, would have been impossible to detect by miR-124 target analysis alone. Moreover, biological functions underlying these regulatory network differences are in line with the phenotypic differences we observed when miR-124 was deleted.

Discussion {#sec3}
==========

Here, we present the first complete cellular human miR-124 knockout model. Previously, only a partial (one locus) miR-124 knockout mouse model had been studied, which showed small brain sizes, axonal mis-sprouting, and enhanced apoptosis ([@bib61]), of which the latter is in line with our findings. However, by a partial knockout, compensatory effects driven by miR-124 paralogs could not be ruled out, and hence only very few of the potential miR-124 targets were identified. In light of previous studies, our findings are quite unexpected, as the initiation of neurogenesis appears to be miR-124-independent. We identified differences in metabolism and cell-fate regulation. For instance, we found that ΔmiR-124 neurons possess higher cholinergic neurotransmitter identity and are more similar to developing human striatum cells, which could be mechanistically explained through a co-expression differential network analysis. Hence, our systems-level analysis of regulatory miR-124-TF networks revealed that miR-124 impacts neuronal subtype differentiation.

Previous studies associated miR-124 with one or a few specific targets responsible for phenotypic changes. We experimentally verified 98 high-confidence targets, confirming that miR-124 acts at a "network-level" rather than controlling only one or a few genes. Still, the fact that we "only" verified 98 targets out of 2,338 genes with reduced 3′ UTR peaks in AGO2-IP samples is surprising and suggests that our approach may not be effective for filtering out all miR-124 targets. However, our data are completely in line with other studies using HITS-CLIP ([@bib65]) and suggest that only a minority of targets bound by a unique miRNA display altered mRNA-levels upon miRNA-perturbation. Still, the list of miR-124 targets could increase since some targets are likely regulated only at the protein level, which could be interesting to study in the future using quantitative high-throughput proteomics, or because of regulatory compensation by other miRNAs or TFs. 38 of the identified miR-124 targets were already experimentally verified, and we further validated 43 using luciferase reporter assays, demonstrating the precision of our AGO2-RIP-seq approach for detecting miR-124 targets in parallel. We detected higher apoptosis rates in ΔmiR-124 neurons, which could be rescued by miR-124 overexpression. Hence, miR-124 regulation is essential for the long-term survival of terminally differentiated neurons by targeting directly but also indirectly a cascade of apoptosis-relevant genes. This provides context to previous studies that found miR-124 dysregulation in cases of Alzheimer disease (AD) or cognitive impairment ([@bib19], [@bib21], [@bib45], [@bib72]), suggesting that alterations in miR-124 may be linked to neurodegenerative disorders via control of apoptosis and neuronal survival, although these observations are controversial ([@bib15], [@bib55]). Our findings highlight the need for cell-type precision for linking certain miRNAs to cellular functions or pathologies. Sampling over many brain cell types might be misleading as neurons die in neurodegenerative diseases; therefore, reduced miR-124 levels are expected but not necessarily causally linked to primarily affected cell types. However, our data robustly support miR-124's neuroprotective function over time.

As 24 direct miR-124 targets were TFs, we were also interested in how the lack of miR-124 regulation affected their networks. We achieved this by a wTO analysis of time course RNA-seq data. In contrast to previous miRNA-TF networks that were based on *in silico* predictions ([@bib25]), our target TF networks were computed from experimentally obtained RNA-seq data. Our recently developed wTO analysis allowed us to specifically account for both positive and negative correlations, which is crucial for analyzing regulatory networks that include transcriptional activators and repressors ([@bib27], [@bib53]). Particularly, we found multiple yet uncharacterized zinc finger proteins such as *ZNF787* associated with miR-124 function. To start functionally characterizing *ZNF787*, we overexpressed *ZNF787* and found many biological processes for neuronal development and functions to be significantly reduced. We thus directly characterized this hereto uninvestigated ZNF as a neuronal feature repressor. Several other ZNFs targeted by miR-124 are human- or primate-specific (i.e., *ZNF138*, *ZNF37*, *ZNF701*, and *ZNF649*), suggesting that primate-specific regulators may have an impact on neuronal differentiation in humans. Besides impacts on coding transcripts, our AGO2-RIP-seq, sRNA-seq and nCounter data further enabled us to study miRNA species in ΔmiR-124 neurons that are normally very likely outcompeted by miR-124 for RISC incorporation in WT neurons. This dynamic change in miRNA regulation most likely masked and thereby reduced molecular outcomes in ΔmiR-124 cells and generally has to be taken into account when studying specific miRNA knockouts. Without studying indirect gene regulatory TF-network effects and dynamic miRNA profile changes, a sophisticated interpretation of miRNA manipulation data will be challenging and incomplete.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**chicken anti-MAP2Abcamab92434rabbit anti-hAGO2[@bib23]N/Amouse anti-AGO2Sigma-AldrichSAB4200085Brilliant Violet 421-anti-NCAMBiolegend318328PE-anti-TRA-1-60BD560193**Chemicals, Peptides, and Recombinant Proteins**BDNFPeprotech450-02GDNFPeprotech450-10dbcAMPSigma-AldrichD0627DoxycyclineSigma-AldrichD9891mTeSR hES medium (complete kit)StemCell Technologies05850BrainPhysStemCell Technologies05790NeuroCult SM1 Neuronal SupplementStemCell Technologies05711N2 Supplement-AThermoFisher Scientific17502048L-Ascorbic AcidSigma-AldrichA0278Matrigel hESC qualifiedCorning354277ROCK inhibitor (InSolution Y-27632)Merck Millipore688001TrypLE ExpressThermoFisher Scientific12604013P3 Primary Cell 4D Nucleofector Kit L/Pulse CB-156LonzaV4XP-3024**Critical Commercial Assays**ApoToxGlo AssayPromegaG6320Dual Luciferase AssayPromegaE1910hsa-miR-124-3p miRCURY LNA miRNA PCR AssayExiqon/QiagenYP002060265S rRNA (hsa) miRCURY LNA miRNA PCR AssayExiqon/QiagenYP00203906Universal cDNA Synthesis Kit IIExiqon/Qiagen203301nCounter human miRNA panel v3NanoStringCSO-MIR3-12**Deposited Data**Raw and analyzed dataThis paper[ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118316](http://ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118316){#intref0010}GRCh38.p10 (Genome Reference Consortium Human Build 38), INSDC AssemblyEnsembl[ensembl.org/info/data/ftp/index.html](http://ensembl.org/info/data/ftp/index.html){#intref0015}Allen BrainSpan Atlas RNA-Seq[@bib50][brainspan.org](http://brainspan.org){#intref0020}Uniprot database[Uniprot.org](http://Uniprot.org){#intref0025}miRTarBase[@bib33][mirtarbase.mbc.nctu.edu.tw](http://mirtarbase.mbc.nctu.edu.tw){#intref0030}miRWalk[@bib17]<http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/>**Experimental Models: Cell Lines**hiPSCs/iNGN[@bib6]; [encodeproject.org](http://encodeproject.org){#intref0040}; based on PGP1, CoriellENCBS369AAA\
GM23338 (primary fibroblasts GM23248)293T/17 cellsATCCCRL-11268**Oligonucleotides**sgRNA oligo miR-124-5'-1/2_1: CACCGATCAAGGTCCGCTGTGAACAThis paperN/AsgRNA oligo miR-124-5'-1/2_2: AAACTGTTCACAGCGGACCTTGATCThis paperN/AsgRNA oligo miR-124-5'-3_1: CACCGTCTATACAATTAAGGCACGThis paperN/AsgRNA oligo miR-124-5'-3_2: AAACCGTGCCTTAATTGTATAGACThis paperN/AsgRNA oligo miR-124-3'-1_1: CACCGCGCGGTGAATGCCAAGAATGThis paperN/AsgRNA oligo miR-124-3'-1_2: AAACCATTCTTGGCATTCACCGCGCThis paperN/AsgRNA oligo miR-124-3'-2/3_1: CACCGCACGCGGTGAATGCCAAGAGThis paperN/AsgRNA oligo miR-124-3'-2/3_2: AAACCTCTTGGCATTCACCGCGTGCThis paperN/A**Recombinant DNA**Plasmid: pSpCas9(BB)-2A-Puro (PX459) V2.0[@bib58]Addgene \#62988Plasmid: PB09-TRE-EF1a-beta-globin-miR-124-GFP-TetO-PuroThis paperWill be provided via AddgenePlasmid: PB09-TRE-EF1a-beta-globin-miR-ctrl-GFP-TetO-PuroThis paperWill be provided via AddgenePlasmid: pmiRGLO-SMAD4[@bib18]Addgene \#78128Plasmid: PB09-TRE-ZNF787-V5-BlastiThis paperWill be provided via AddgenePlasmid: pSMPUW-miR-GFP-PuroCell Biolabs322001Plasmid: PB09-TRE-ZNF787-V5-BlastiThis paperWill be provided via Addgene**Software and Algorithms**SegemehlN/A<http://www.bioinf.uni-leipzig.de/Software/segemehl/>SamtoolsN/A<http://samtools.sourceforge.net/>FASTQCN/A<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>GSNAPN/A<https://github.com/juliangehring/GMAP-GSNAP>featureCountsN/A<http://bioinf.wehi.edu.au/featureCounts/>TopHat2[@bib68]<https://github.com/infphilo/tophat2>rnacounterN/A<https://github.com/jdelafon/rnacounter>Cuffdiff[@bib68]<http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/>DESeq2[@bib44]<http://bioconductor.org/packages/release/bioc/html/DESeq2.html>Weighted topological overlap (wTO)[@bib27]<https://CRAN.R-project.org/package=wTO>Package SOMN/A<https://CRAN.R-project.org/package=som>CoDiNA[@bib28]<https://CRAN.R-project.org/package=CoDiNA>REVIGON/A<http://revigo.irb.hr>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Volker Busskamp (<volker.busskamp@tu-dresden.de>). All plasmids generated within this study are available at [Addgene.org](http://Addgene.org){#intref0115}.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell Lines {#sec4.3.1}

iNGN cells (<https://www.encodeproject.org>, accession number: ENCBS369AAA) were previously described ([@bib6]). hiPSCs were cultured in mTeSR 1 media (05850, StemCell Technologies) on standard tissue culture plates coated with hESC-qualified Matrigel matrix (354277, Corning, incubated 45 min at room temperature) under standard conditions (5 % CO~2~, 37°C). For passaging, hiPSCs were dissociated with TrypLE Express (12604013, Thermo Fisher Scientific), washed with DPBS (pH 7.2; 14190169, Thermo Fisher Scientific), spun down (400 × g) and replated using mTESR with 3 μg/ml InSolution Y-27632 rho kinase inhibitor (688001, Merck Millipore) or frozen in mFreSR media (05854, StemCell Technologies).

CRTD5 hiPSCs were generated from BJ fibroblasts (CRL-2522, ATCC) at the CRTD iPS facility. Reprogramming was perfomed using the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific) according to the manufacturer's guidelines for transduction. Following transduction, the cells were cultured with ReproTeSR medium (05920, StemCell Technologies) on hES-qualified Matrigel for 18 to 21 days. Once stem cell colonies were sufficiently grown, the clonal colonies were mechanically isolated and expanded using mTeSR medium. Passaging was carried out similarly to iNGN cells. ReLeSR (05872, StemCell Technologies) was used for detachment in clumps. Pluripotency of the hiPS cells was tested using flow cytometry with Alexa Fluor 488-coupled anti-Oct3/4 (560253), PE-coupled anti-Sox2 (560291), V450-coupled SSEA-4 (561156) and Alexa Flour 647-coupled anti Tra-1-60 (560850, all BD Pharmingen) according to the manufacturer's protocol ([Figure S2](#mmc1){ref-type="supplementary-material"}K). Furthermore, CRTD5 cells were tested positive for their differentiation capability for all three germ layers (data not shown). Karyotyping was performed as stated for iNGN WT/ΔmiR-124 cells ([Figure S2](#mmc1){ref-type="supplementary-material"}L).

Stable integration of an inducible Neurog1/2 cassette to generate CRTD5-iNGN cells was performed using the PiggyBac transposon system. All promoter elements and open reading frames between the 5' core insulator and the SV40 polyA of the PiggyBac vector backbone PB-TRE-dCas9-VPR13 (Addgene plasmid \#63800; [@bib10]) were removed using SpeI/SalI and replaced with PCR-amplified Neurog1/2 after a doxycycline-inducible promoter from the lentiviral iNGN construct (Addgene plasmid \#61471; [@bib6]). Plasmids were transformed into chemically competent bacteria for amplification (One Shot Stbl3, Thermo Fisher Scientific). 10 μg of the plasmid were mixed with 2 μg of Super PiggyBac Transposase Expression Vector (PB210PA-1-S, Biocat) and electroporated to CRTD5 cells with the Lonza 4D X-unit, pulse CB-156 and the P3 Primary Cell 4D-Nucleofector Kit L (V4XP-3024, Lonza).

293T/17 cells (CRL-11268, ATCC) were cultured with DMEM + 10 % FBS (41966052, 10100147, Thermo Fisher Scientific) and passaged with trypsin-EDTA (25300054, Thermo Fisher Scientific).

Method Details {#sec4.4}
--------------

### Neurogenin-1/2-Induced Differentiation {#sec4.4.1}

0.5 μg/ml doxycycline (D9891, Sigma-Aldrich) was used to induce Neurog1 and -2 genes. After 4 dpi, half of the mTeSR 1 media was replaced with supplemented BrainPhys media (05790, StemCell Technologies), replaced daily until 7 dpi and further once per week. The following BrainPhys supplements were used for 10 ml media: 200 μl NeuroCult™ SM1 Neuronal Supplement (05711, Stemcell Technologies); 100 μl N2 Supplement-A (17502048, Thermo Fisher Scientific); 20 μl of 10 μg/ml recombinant human BDNF to a final concentration of 20 ng/ml (450-02, Peprotech); 20 μl of 10 μg/ml recombinant human GDNF to a final concentration of 20 ng/ml (450-10, Peprotech); 98 μl of 50 mg/ml dibutryl-cAMP to a final concentration of 1 mM (D0627, Sigma-Aldrich); 50 μl of 40 mM ascorbic acid to a final concentration of 200 nM (A0278, Sigma-Aldrich); and 100 μl of 100× penicillin-streptomycin (15140122, Thermo Fisher Scientific). After stable integration of the Neurog1/2 cassette to CRTD5 cells, the cells were differentiated similarly to iNGN cells.

### iPSC Differentiation into mDA Neurons {#sec4.4.2}

Midbrain dopaminergic (mDA) neurons were generated via a small-molecule-based protocol ([@bib60]). For neural induction, confluent iPSCs were disaggregated using Accutase and subsequently resuspended as clumps in N2B27 medium (Neurobasal-A (10888022), DMEM-F12 (11330032), N2 (17502048), B27 (12587010), GlutaMAX (35050061), 15 mM HEPES (15630080); Thermo Fischer Scientific) supplemented with 1 μM dorsomorphin (3093, Tocris), 10 μM SB431542 (ab120163, Abcam), 5 μM ROCK inhibitor (Y-27632, 688001, Merck), 3 μM CHIR (CHIR-99021, Tocris), 200 μM ascorbic acid (AA, A0278, Sigma-Aldrich), and 0.5 mM purmorphamine (PMA, sc-202785, Santa Cruz Biotechnology) via embryoid body formation. Six days after neural induction, embryoid bodies were dissociated into smaller pieces using a 1000 μl pipette and plated on Matrigel (Corning)-coated 12-well plates. For expansion, smNPCs were cultured using N2B27 medium supplemented with 3 μM CHIR, 0.5 μM PMA, and 200 μM AA. To differentiate mDA neurons, smNPCs were patterned by plating smNPCs into N2B27 medium containing 0.5 mM PMA, 2 ng/ml human BDNF (450-02), 1 ng/ml GDNF (450-10, both Peprotech), and 200 mM AA. Maturation was induced by switching the medium to N2B27 medium containing 2 ng/ml BDNF, 2 ng/ml GDNF, AA, 1 ng/ml TGF-b3 (100-36E, Peprotech), 100 μM dibutryl-cAMP (D0627, Sigma-Aldrich), and 2 ng/ml activin A (120-14, Peprotech, first 2-3 days 5 ng/ml). For immunocytochemistry, differentiating mDA neurons were replated as single cells on day 14 of the differentiation onto coverslips and fixed on day 21. NEUN expression was quantified by counting positively stained nuclei using Fiji. Data were tested for significance using an unpaired Student's t-test. Data are presented as mean ± SEM.

### Knockout of miR-124 Loci in Human iPSCs {#sec4.4.3}

sgRNA were designed by the MIT's CRISPR web tool (<http://crispr.mit.edu/>; [@bib32]). sgRNA sequences and corresponding oligos were used according to [Table S2](#mmc1){ref-type="supplementary-material"}. All oligos were cloned into the vector pSpCas9(BB)-2A-Puro (PX459) V2.0 (a kind gift from Feng Zhang, Addgene plasmid \#62988) as described in [@bib58]. Four different sgRNA-expressing constructs were co-electroporated (10 μg per vector) into iNGN and CRTD5 cells by the Lonza 4D X-unit, pulse CB-156, and the P3 Primary Cell 4D-Nucleofector Kit L (V4XP-3024, Lonza), according to the manufacturer's guidelines. Cells were plated sparsely, and selected for PX459 integration after 24 h with puromycin. Grown colonies, derived from single cells, were picked and genotyped with primers specific for all miR-124 loci ([Table S3](#mmc1){ref-type="supplementary-material"}) using the Kapa Hifi Mastermix (KR0370, Kapa Biosystems) or Takara PrimeStar Max Mastermix (R045B, Takara Bio) according to the manufacturer's protocol.

Potential off-targets (score ≤ 0.9 according to design tool; <http://crispr.mit.edu/>; [@bib32]) were tested by Sanger sequencing of corresponding PCR products that were amplified from genomic DNA using specific primers for the iNGN cell line ([Table S4](#mmc1){ref-type="supplementary-material"}). 20 metaphase states from each cell line were karyotyped using G-banding ([@bib63]) via the iPS facility of the Center for Molecular and Cellular Bioengineering (CMCB) at the Institute of Human Genetics, University Clinics Jena, Germany, to test for chromosomal alterations.

### Imaging and Image Analysis {#sec4.4.4}

Fluorescence imaging was performed on a Zeiss Axio Observer Z1 inverted fluorescence microscope. Images were processed using Fiji; the images were adjusted in the same way for every picture and channel from each experiment. Microscopic characterization and quantification of phenotypic differences were performed using an EVOS FL system (ThermoFisher Scientific) and manual counting using Fiji. Qualitative Brightfield images and images showing GFP expression of live cells were corrected for equal illumination throughout the well. Statistical comparison of morphological parameters was performed using an unpaired Student's t-test for two groups. Data are presented as mean ± SEM.

### miR-124 and ZNF787 Overexpression {#sec4.4.5}

For miR-124 overexpression, a doxycycline-inducible promoter, the genomic miRNA-124 locus (±100 bp) placed within the human beta-globin intron (from pCMV-MIR vector, Origene) and a GFP-puromycin reporter were inserted into the SpeI/SalI linearized PiggyBac vector backbone PB-TRE-dCas9-VPR13 (Addgene plasmid \#63800; [@bib10]) using isothermal assembly ([@bib22]) leading to the miR-124 expressing construct PB09-TRE-EF1a-beta-globin-miR-124-GFP-TetO-Puro. The control construct PB09-TRE-EF1a-beta-globin-miR-ctrl-GFP-TetO-Puro (EGFP-ctrl) was identical to PB09-TRE-EF1a-beta-globin-miR-124-GFP-TetO-Puro, but lacked the miR-124 hairpin, which resulted in a less bipolar ground state of the neurons due to the high GFP expression. The respective constructs were electroporated into iNGN cells and after two days selected for stable integration using 3 μg/ml puromycin. ZNF787 overexpression was performed using the same PiggyBac vector (PB-TRE-dCas9-VPR13) with addition of a doxycycline-inducible promoter, PCR-amplified ZNF787 (variant 1), a V5 tag and a blasticidin resistance gene after via isothermal assembly (construct PB09-TRE-ZNF787-V5-Blasti). Stable integration was assured by administration of 15 μg/ml blasticidin for at least three days.

### Quantitative Real-Time PCR {#sec4.4.6}

For gene expression analysis, 250,000 cells of each corresponding sample group were seeded onto Matrigel-coated 12-well plates and induced with doxycycline. At 4 dpi, cells were detached with TrypLE Express (12604013, Thermo Fisher Scientific), spun down, and lysed with Qiazol (miRNeasy Mini Kit, 217004, Qiagen). The phases were separated with Phase Lock Gel tubes (heavy, 2 ml, 733-2478, 5PRIME) and the aqueous phase was cleaned-up with the miRNeasy Kit. 500 ng of the resulting RNA was reverse transcribed with the High-Capacity cDNA Reverse Transcription Kit (4368814, Thermo Fisher Scientific) or, for miRNA-specific analysis, the Universal cDNA Synthesis Kit with 5 ng input, respectively (203301, Exiqon). Primers for miR-124 were purchased from Exiqon/Qiagen (YP00206026). At least three biological replicates were used per sample and normalized to 5S RNA (YP00203906, Exiqon/Qiagen). For ZNF787, the expression analysis was conducted with ZNF787-specific primers and normalized to beta-Actin (ZNF787_for, CCAGTCACGAGAACCCAGTG, ZNF787_rev, CTCTGCGAGAAGGTCTTGCC; ACTB_for, CCTCGCCTTTGCCGATCC; ACTB_rev, CGCGGCGATATCATCATCC). Quantitative measurements were performed with the StepOnePlus Real-Time PCR System (Thermo Fisher Scientific) and Power SYBR Green PCR Master Mix (4367659, Thermo Fisher Scientific). Statistical comparison was based on the delta-delta-Ct method and performed using unpaired Student's t-tests and Holm-Sidak correction for multiple comparisons. Data are presented as mean ± SEM.

### SDS/Page Electrophoresis and Western Blot {#sec4.4.7}

For sample preparation, cells were lysed in RIPA buffer (R0278, Sigma-Aldrich) mixed with protease inhibitor cocktail (1:25, 118735, Sigma-Aldrich) for 45 min on ice. Cells were then centrifuged at 10,000 × g for 10 min at 4°C. The supernatants were collected and transferred to a fresh tube. Samples were boiled at 95°C for 5 min in Laemmli buffer (1610737, BioRad). Proteins were separated on a 4--12 % SDS/PAGE gel. Gels were then transferred using the Transblot-Turbo Transfer system (BioRad). After transfer, membranes were blocked for 1 h in Tris-buffered saline (T5912, Sigma-Aldrich) with 0.1 % Tween20 (TBST, P1379, Sigma-Aldrich) and 5 % (wt/vol) non-fat dry milk (70166, Sigma-Aldrich) followed by overnight incubation at 4°C. The primary antibody was mouse anti-AGO2 (1:1,000; SAB4200085, Sigma-Aldrich). After two TBST washing steps of 15 min, membranes were incubated for 1 h at room temperature with HRP-conjugated secondary antibodies: anti-mouse (1:5,000; sc-2005, Santa Cruz Biotechnology). Actin staining was done using a monoclonal mouse anti-β-actin HRP (1:100,000; A3854, Sigma-Aldrich). Membranes were developed with the ECL Prime Western Blotting Detection Reagent (RPN2232, GE Healthcare). The signal was measured using a Chemidoc MP system (BioRad) and band intensities were quantified by densitometry using the ImageJ software.

### Neurite Outgrowth Assay {#sec4.4.8}

iNGN cells (WT or ΔmiR-124) were seeded at a density of approximately 50,000 cells/cm^2^ and induced with 0.5 μg/ml doxycycline. At 4 dpi, clusters of neurons were mechanically detached with a pipette tip und transferred to a PDL-laminin-coated 96-well plate for imaging (655090, Greiner). The next day pictures were taken every 10 min over a total time of 1 h with a Leica DMI6000 live-cell chamber. Neurite length was manually quantified from frame to frame using Fiji. Statistical comparison was performed using an unpaired Student's t-test for two groups. Data are presented as mean ± SEM.

### Flow Cytometry {#sec4.4.9}

Cells were detached using TrypLE Express (12604013, Thermo Fisher Scientific), washed with DPBS without calcium and magnesium (14190169, Thermo Fisher Scientific), stained with PE-anti-TRA-1-60 (560193, BD) or the isotype control (555584, BD) and Brilliant Violet 421-anti-NCAM (318328, Biolegend) or the isotype control (400157, Biolegend). After staining for 1 h on ice, the cells were resuspended in FACS buffer comprising DPBS, 10 % fetal bovine serum (26140-079, Thermo Fisher Scientific), and 10 mM EDTA (15575-038, Thermo Fisher Scientific). A BD LSR II flow cytometer and BD FACSDiva software were used for analysis. Median fluorescence signal was used as measure for marker expression. Statistical comparison was performed using unpaired Student's t-tests and Holm-Sidak correction for multiple comparisons. Data are presented as mean ± SEM.

### Apoptosis and Viability Assay {#sec4.4.10}

WT and ΔmiR-124 were seeded and differentiated consecutively according to the time frame from 0 to 14 dpi and all samples were measured with a SynergyNeo2 plate reader (BioTek) on the same day. The ApoToxGlo assay (G6320, Promega) was conducted according to the manufacturer's protocol. Statistical comparison was performed using unpaired Student's t-tests and Holm-Sidak correction for multiple comparisons. Data are presented as mean ± SEM.

### Luciferase Reporter Assays {#sec4.4.11}

3' UTRs of potential miR-124 targets from the RIP-Seq Analysis were cloned into the pmiRGLO-SMAD4 vector (a gift from Heidi Schwarzenbach, Addgene plasmid \#78128) ([@bib18]) using NheI and XbaI, together with specific primers for the 3' UTR region ([Table S5](#mmc1){ref-type="supplementary-material"}). A reversed miR-124 sponge sequence -- not binding miR-124 -- served as negative control for the assay. These constructs were transfected into four independent replicates of 293T/17 cells together with a miR-124 overexpressing construct (pSMPUW-miR-GFP-Puro with integrated miR-124 according to the manufacturer's protocol; or a control construct (Cell Biolabs) using polyethylimine 'Max' (24765-2, Polyscience). 48 h after transfection, the cells were harvested using the dual-luciferase assay kit (E1910, Promega). Luciferase activity (firefly and renilla) was monitored using a SynergyNeo2 (BioTek) ([Table S6](#mmc3){ref-type="supplementary-material"}), normalized to the negative controls and tested for significance using unpaired Student's t-test and Holm-Sidak correction for multiple comparisons. Data are presented as mean ± SEM.

### Electrophysiological Measurements {#sec4.4.12}

During the experiment, single cover slips with WT or ΔmiRNA-124 neurons were kept in filtered (0.2 μm) extracellular solution of the following composition (mM): NaCl 130 (S3014, Sigma-Aldrich), HEPES 20 (15630056, ThermoFisher Scientific), glucose 10 (CRTD media kitchen), KCl 5 (1049360250, Merck), CaCl~2~ 2.5 (CRTD media kitchen), MgCl~2~ (CRTD media kitchen), pH 7.3 with NaOH (1064950250, Merck). Neurons were localized under an upright microscope (Zeiss Examiner.A1 Axio) equipped with a water-immersion 20× objective (420957-9900, Zeiss). Neurons were selected for single-cell patch-clamp using whole-cell configuration. Microelectrodes had resistances of ∼6 MΩ, were pulled from borosilicate glass (GB150EFT-8P, Science Products) with a P-1000 programmable horizontal puller (Sutter Instruments), and contained a filtered (0.2 μm) intracellular solution of the following composition (mM): KCl 130, HEPES 20, EGTA 10 (324626, Merck), CaCl~2~ 0.25, pH 7.3 with KOH. The head stage was attached to a digitally controlled micro-manipulator (Luigs & Neumann SM-7) and connected to a multi-clamp 700 amplifier (Molecular Devices): analogue electrophysiological data were low-pass filtered at 6 kHz and subsequently converted to digital values at a sample rate of 20 kHz using a Digidata 1440A (Molecular Devices). Data was transferred to a PC using pClamp software (10.3, Molecular Devices) and analyzed using Clampfit software (10.3, Molecular Devices) and custom Python code with the neo package ([neo.readthedocs.io](http://neo.readthedocs.io){#intref0135}). Pipette capacitance was always compensated for. For each neuron, several −10 mV pulses were applied after opening the cell to measure the capacitance in voltage-clamp mode at −60 mV and subsequently averaged. Capacitance was calculated as the integral of the capacitive current (carried charge) at offset of pulse, divided by the pulse amplitude. Cell capacitance was compensated for before further voltage clamp recordings. Peak and steady-state currents were analyzed by applying incremental depolarizing voltage pulses from −60 to 55 mV in 5 mV steps. Membrane potential was taken as the median of a 30 s recording in current-clamp mode (I = 0). Spiking behavior was assessed by injecting constant current to hold cells at around −70 mV. To find a neuron's maximum number of spikes, 500 ms increasing current steps were injected from −30 to 150 pA in 10 pA steps. Action potentials were detected using a threshold at −10 mV. All membrane voltages were corrected for a liquid junction potential, which was calculated to be 0.4 mV. No cover slip was measured for longer than 1 h.

### Immunocytochemistry {#sec4.4.13}

Cells were grown on Matrigel-coated glass coverslips and fixed for 10--15 min with 4 % paraformaldehyde (15713, Electron Microscopy Sciences) in PBS (14040-117, ThermoFisher Scientific) and subsequently washed twice with PBS. Permeabilization and blocking was performed using 10 % NDS (S30-100ML, Merck-Millipore), 0.5 % Triton X-100 (Sigma Aldrich), and 1 % BSA (15260037, ThermoFisher Scientific) in PBS for 20 min. Primary antibodies were applied overnight at 4°C in 3 % NDS in PBS. Subsequently, the samples were washed (10 min) three times with PBS, the secondary antibodies and DAPI (10236276001, Sigma-Aldrich) were applied for 1 h at room temperature in 3 % NDS in PBS. Three washes (10 min) with PBS-T (0.05 % Tween-20, P1379-250ML, Sigma Aldrich) were performed. Cells were mounted in Prolong Gold Antifade (P36934, Thermo Fisher Scientific).

Primary antibodies used in this study were mouse anti-NESTIN (1:300, MAB1259, R&D), goat anti-SOX1 (1:300, AF3369, R&D), rabbit anti-PAX6 (1:300, 901301, Biolegend), goat anti-SOX2 (1:300, 17320, Santa Cruz), mouse anti-FOXA2 (1:300, 101060, Santa Cruz), rabbit anti-TH (1:300, AB152, Merck Millipore), chicken anti-TUBBIII (1:700, AB9354, Merck Millipore), chicken anti-MAP2 (1:700, ab92434, Abcam), mouse anti-NEUN (1:700, MAB377, Merck Millipore), mouse anti-NCAM (1:700, 610921, BD), goat anti-DCX (1:700, sc-8066, Santa Cruz), rabbit anti-GFAP (1:700, ab16997, Abcam), and rabbit anti-dopamine (1:300, AB122S, Merck Millipore). Secondary antibodies were obtained from Thermo Fisher Scientific and were conjugated to AlexaFluor fluorochromes (1:1,000). Anti-rabbit-Cy3 (1:1,000, 711-165-152, Jackson labs) was also used.

### RNA-Interacting Protein Immunoprecipitation {#sec4.4.14}

Cell pellets from approximately 50 million cells were homogenized, lysed in ice-cold lysis buffer (10 mM HEPES (pH 7.3, ThermoFisher Scientific), 100 mM KCl (1049360250, Merck), 0.5 % NP40 (NP40S, Sigma-Aldrich), 5 mM MgCl~2~, 0.5 mM dithiothreitol (DTT, DTT-RO, Sigma-Aldrich), protease inhibitors (118735, Sigma-Aldrich), recombinant RNase inhibitors (10777019, ThermoFisher Schientific), 1 mM PMSF (36978, ThermoFisher Scientific) using TissueLyser LT (50 Hz, 2 min, Qiagen). For lysate clearing, homogenates were centrifuged for 15 min at 16,200 × g, 4°C. A 50 μl sample was taken as a pre-IP sample. The RIP samples were incubated with Dynabeads Protein G beads (10009D, ThermoFisher Scientific) coated with anti-hAGO2 antibody (a gift from JA Nelson) ([@bib23]) for 24h at 4°C with end-over-end rotation. After incubation, beads were collected on a Dynamagnet (1 min, on ice, ThermoFisher Scientific) and gently resuspended in low-salt NT2 buffer (50 mM Tris-HCl (pH 7.5, T1503, Sigma-Aldrich)), 1 mM MgCl~2~, 150 mM NaCl (S3014, Sigma-Aldrich), 0.5 % NP40, 0.5 mM dithiothreitol, 1 mM PMSF, protease inhibitors, recombinant RNase inhibitors). The beads were transferred to a new collection tube and washed with low salt NT2 buffer, followed by two washes with high salt NT2 buffer (50 mM Tris-HCl, pH 7.5), 1 mM MgCl~2~, 600 mM NaCl, 0.5 % NP40, 0.5 mM DTT, protease inhibitors, 1 mM PMSF, recombinant RNase inhibitors). The solution containing the RNA was then transferred to Qiazol (Qiagen). Subsequently, RNA was isolated from RIP and pre-RIP samples according to the miRNeasy micro kit protocol (217084, Qiagen). The size distribution of the samples and the quality was checked with a Bioanalyzer RNA 6000 Pico Chip (5067-1513, Agilent Genomics).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical details for each experiment are described in the Results and corresponding Methods sections as well as in the Figure legends.

### Sequencing and Analysis of RIP Samples {#sec4.5.1}

cDNA libraries of three independent WT whole-cell RNA, ΔmiR-124 whole-cell RNA, WT-AGO2 RIP, and ΔmiR-124-AGO2 RIP samples for 0 and 4 dpi were prepared using NEBNext Ultra I Directional RNA Library Prep Kit for Illumina (E7420, NEB) with 900 ng input at the CMCB Sequencing Facility at TU Dresden ([Table S7](#mmc4){ref-type="supplementary-material"}). PolyA selection, fragmentation, first strand and second strand cDNA synthesis, and purification were performed in combination with Agencourt AMPure Kit (A63880, Beckman Coulter) and repair/dA-tailing of the cDNA. Adapters were ligated to dA-tailed cDNA and size-selected using AMPure XP Beads (Beckman Coulter). RIP samples were not polyA-selected. Index primers (Illumina) were used to index library constructs, and a PCR was performed using NEBNext Q5 2X PCR Master Mix (M0543S, NEB). Libraries were purified using Agencourt AMPure Kit. Libraries were pooled and sequenced on a HiSeq 2500 (Illumina), resulting in ca. 33-56 million single-end 75 bp reads.

RIP-Seq reads were pre-processed (includes demultiplexing, barcode trimming, and adaptor removal) using BBDuk from the BBMap toolkit ([github.com/BioInfoTools/BBMap](http://github.com/BioInfoTools/BBMap){#intref0140}, v36.14). After quality control with FASTQC ([bioinformatics.babraham.ac.uk/projects/fastqc/](http://bioinformatics.babraham.ac.uk/projects/fastqc/){#intref0145}, v0.11.4), reads were mapped to the human genome assembly hg38/GRCh38 using Segemehl ([bioinf.uni-leipzig.de/Software/segemehl/](http://bioinf.uni-leipzig.de/Software/segemehl/){#intref0150}, v0.2.0-418). Uniquely mapped reads were extracted for further analysis.

For differential expression analysis of the whole-cell RNA-Seq data reads were mapped to the human reference genome (hg38) using GSNAP ([research-pub.gene.com/gmap/](http://research-pub.gene.com/gmap/){#intref0155}) with ENSEMBL annotation 81 and counted using featureCounts (<http://bioinf.wehi.edu.au/featureCounts/>; v1.5.2). Differential expression analysis was performed using DESeq2 ([bioconductor.org/packages/DESeq2/](http://bioconductor.org/packages/DESeq2/){#intref0165}; [@bib44]) on uniquely mapped reads.

### RIP-Seq Binding Site Definition and Filtering {#sec4.5.2}

RIP-Seq identifies target transcripts/genes, sacrificing the high resolution of CLIP-Seq for the advantage of not performing a crosslinking procedure. Higher resolution and crosslinking techniques such as CLASH or CLEAR-CLIP, will most likely identify additional and lower abundant targets. However, a key aspect of our study is the combination of native AGO2-IP with expression data derived from RNA-Seq. This allows to normalize IP signal to target expression, adding a quantitative layer to our data, which was used to compare relative levels of miRNAs and miRNAs associated with the RISC complex between WT and ΔmiR-124 cells. The resulting list of potential miR-124 targets identified by RIP-Seq was intersected with a set of databases, which contain experimentally validated targets as well as predicted targets ([Tables S7](#mmc4){ref-type="supplementary-material"}, [S8](#mmc5){ref-type="supplementary-material"}, and [S9](#mmc6){ref-type="supplementary-material"}). These target predictions were conducted with seed regions, starting from a length of 6 nts. The combination of validated and predicted targets leads to a list of annotated miR-124 targets, rendering this initial set of targets most likely too large. Our AGO2-RIP-Seq data allowed us to identify bona fide miR-124 targets in iNGN cells, and relate our findings to well-established databases: the results confirm that we had identified biologically relevant targets. A binding site is defined as a region with a significantly higher number of read pile-ups than would be expected by chance at a given genomic position. We used a custom filtering method to split potential binding regions once certain height thresholds were reached. Cutoffs were defined based on signals detected in known miR-124 targets. Regions with a summit signal below 10 read pile-ups are considered background and were discarded. With a sliding window approach, starting from the summit, a binding site is first split when its height falls below 20 % of the summit signal. Emerging sub-sites with a summit above this cutoff and 10 pile-ups are then recursively split when their signal falls below 5 % of their summit, which also preserves regions with only weak signal. Replicates of each experimental setup were analyzed separately, and only peaks occurring in all replicates were considered for further analysis. Binding sites derived from uniquely mapped reads were annotated using the ENSEMBL Perl API for human annotation v90. Data were filtered using R and Excel (Microsoft) using Targetscan, miRanda, RNA22, and miRWalk ([@bib17], [@bib34], [@bib39], [@bib51]). Furthermore, miRTarBase for experimentally validated miRNA-mRNA interactions was used to extract validated targets of miR-124 ([@bib33]).

### RNA-Seq from Total RNA, Processing and Data Analysis {#sec4.5.3}

Samples were prepared as for qRT-PCR analysis in seven biological replicates for sequencing of total RNA using the miRNeasy mini kit (Qiagen) and Phase Lock Gel tubes (heavy, 2 ml, 733-2478, 5PRIME) for enhanced phase separation according to the manufacturer's guidelines. cDNA libraries were prepared as RIP-Seq samples. Fasta files were processed and controlled for quality as RIP-Seq. Counts were computed using rnacounter (<https://github.com/jdelafon/rnacounter>) using RPKM and raw counts, from the v25 gencode annotation ([Tables S12](#mmc9){ref-type="supplementary-material"} and [S13](#mmc10){ref-type="supplementary-material"}). Data comparing WT, ΔmiR-124 and ZNF787 overexpression were mapped and counted similarly to RIP-Seq whole-cell samples ([Table S14](#mmc11){ref-type="supplementary-material"}). Differential expression (DE) and principal component analysis was calculated using DESeq2 with raw counts. The contrast used was ΔmiR-124 versus WT. Normalized fold changes (nFC) of the significant genes (Benjamini & Hochberg adjusted p-values \< 0.05; [@bib4]) were used to construct the timecourse analysis. Z-scores were used to visualize expression analysis per gene. For the ZNF787-associated genes, counts were rlog-transformed with DESeq2 prior to standardization.

### Small RNA Quantification and Analysis {#sec4.5.4}

For small RNA sequencing (sRNA-Seq), cDNA libraries were prepared using NEXTFlex Small RNA Library Prep V3 (NOVA-5132-06, BIOO Scientific) with 50 ng input and 22 PCR cycles. Sequencing was performed using a HiSeq 2500 (Illumina). A similar approach as used for RIP-Seq analysis was also applied to sRNA-Seq data. After pre-processing, quality control, and mapping, read profiles were filtered using the same custom approach as for RIP-Seq data ([Table S10](#mmc7){ref-type="supplementary-material"}). Due to the nature of sRNA-Seq data, multi-mapped reads were considered, but were neglected for the differential expression analysis. Regions that passed the filtering steps and were called in all replicates were again annotated using the ENSEMBL Perl API v90; peaks overlapping miRNA annotation were selected for downstream processing. Differential expression analysis was performed using DESeq2 on uniquely mapped reads as with RNA-Seq data. Complementarily, the nCounter human miRNA panel v3 (CSO-MIR3-12, NanoString) from 100 ng total RNA isolated, as stated for RNA-Seq, was used in combination with the Prep Station and the Digital Analyzer according to the manufacturer's guidelines. nCounter-miRNA counts were analyzed similarly to sRNA-Seq counts using DESeq2 ([Table S11](#mmc8){ref-type="supplementary-material"}). For the computation of expression profiles, nCounter-derived raw counts were normalized to the corresponding counts of housekeeping genes on a per-replicate basis. The mean-normalized counts were used for data visualization. Of note, the nCounter miRNA Expression Assay kit did not include probes for all human miRNAs and not all miRNA probes were optimal ([@bib6]). For our analysis, we only focused on miRNAs that passed an nCounter threshold of \>200 raw counts (corresponding to ∼0.004 normalized counts to housekeeping genes) at least in one of the 12 samples.

### Neuronal Profiling Using BrainSpan Atlas {#sec4.5.5}

To align the iNGN read data to the human genome (hg38/hg19), TopHat2 v2.1.0 (Tuxedo suite; [@bib68]; [ccb.jhu.edu/software/tophat](http://ccb.jhu.edu/software/tophat){#intref0175}) was used. We determined the gene expression levels (FPKM) and the differentially expressed (DE) genes using Cuffdiff (<http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/>, v2.2.1; Gencode v26/v10). To identify the genes related to brain development, we calculated the 1,000 highest DE genes of the WT and ΔmiR-124 cells at 4, 7 and 14 dpi with respect to 0 dpi, respectively. Subsequently, the Pearson correlation coefficient was derived for the remaining FPKMs of each BrainSpan sample and our cell lines at 4, 7 and 14 dpi. The BrainSpan Atlas by the Allen Institute ([www.brainspan.org](http://www.brainspan.org){#intref0185}; [@bib50]) contains RNA-Seq data from 16 cortical and subcortical brain regions from both female and male human individuals. The samples span from 8 postconceptional weeks to 40 years (29 timepoints in total). In order to test whether a brain region had a higher correlation to any given age, we determined if the differences in means was larger than twice the standard deviation of samples with a similar age. For all analyses, we combined cerebellum and cerebellar cortex data from the BrainSpan Atlas since their timepoints did not overlap and calculated the mean of the FPKMs between individuals for each timepoint and region. Graphical brain illustrations were performed as previously described ([@bib78]).

### Self-Organizing Map Clustering {#sec4.5.6}

TFs that were differentially expressed at all timepoints from 1 to 4 dpi were clustered according to their nFC pattern over time using the Self Organizing Maps (SOM) algorithm ([@bib79]), implemented in R using the package som (<https://CRAN.R-project.org/package=som>). The number of clusters was increased until the q-error of each group was reduced, with the average distortion measure under 10. The membership of the genes to each SOM cluster was used to color the genes in the (target-) TF-TF network analysis.

### Weighted Topological Overlap (wTO) {#sec4.5.7}

The wTO is a measure of how a set of genes of interest is correlated. Having a high absolute wTO means that the expression of both genes is highly (positively or negatively) correlated. The wTO computes not only the signed weight of this relationship, but also the probability of the relationship being random. The R package wTO (<https://cran.r-project.org/web/packages/wTO/index.html>; [@bib27]) was used to calculate the wTO of the (target-) TF-TF networks ([Table S15](#mmc12){ref-type="supplementary-material"}). The correlation between a set of genes was corrected using all the other genes present, thus reducing the noise and the false positives, and taking into account the commonalities of those genes. The parameters used in this calculation were Pearson product-moment correlation coefficient and 1000 bootstraps resampling. The final results were filtered to a probability of 0.10 for having random wTO. The wTO was calculated based on RPKM values. Genes with RPKM \< 5 for each day were removed. From the total of 56269 mapped transcripts from the RNA-Seq dataset, 39,275 are considered to be expressed, using the criteria previously described. Only TFs from the RIP-Seq high probability target list (assembled from the Gene Regulatory Factor (GRF) Catalog ([@bib5]) were considered for the network analysis: these are associated with gene ontology terms for regulation of transcription, DNA-dependent transcription, RNA polymerase II transcription co-factor and co-repressor activity, chromatin binding, modification, remodeling, or silencing, among others. The wTO R package was used to visualize the interactive plots. igraph ([igraph.org/r/](http://igraph.org/r/){#intref0200}) and network ([CRAN.R-project.org/package=network](https://cran.r-project.org/package=network){#intref0205}) R packages were used to visualize the developmental network. Human or primate specificity was judged according to the Uniprot database ([uniprot.org](http://uniprot.org){#intref0210}).

### GO Enrichment Analysis {#sec4.5.8}

GO enrichment analysis was conducted using the R package topGO ([bioconductor.org/packages/topGO](http://bioconductor.org/packages/topGO){#intref0215}) using all expressed genes (TPM \> 0.01 or average RPKM \> 10) as background for each day. The GO enrichment analysis for days 7 and 14 was done separately for up- and down-regulated genes, according to the DE analysis. Semantic clustering was performed with REVIGO ([revigo.irb.hr](http://revigo.irb.hr){#intref0220}) using the SimRel measure and allowed similarity of 0.9).

### Co-expression Differential Network Analysis (CoDiNA) {#sec4.5.9}

Identifying similarities and differences between the WT and ΔmiR-124 wTO-TF networks was performed using the CoDiNA method implemented in the R package CoDiNA ([Table S1](#mmc2){ref-type="supplementary-material"}) ([@bib28]), a recently-developed method to classify links and nodes according to Φ categories, to its commonalities, differences and specificities. Links are considered to be common (α) if they belong to a set of networks (WT and ΔmiR-124 for each day) with the same sign and similar strength. If the sign changes from one network to another, the link is considered different (β). If a particular link belongs to one network only, it is considered to be specific to this network (γ). α and β categories are intersections of correlated genes between WT and ΔmiR-124: γ links are exclusive for one condition. The classification of the interactions according to these concepts is central to understand how the ΔmiR-124 networks are affected in their TF interactions during the time course. The distance of each link to the origin is calculated in order to score links that are more common, different or specific. Links with a normalized Φ distance greater than 0.5 were kept for further analysis.

In order to define the category a TF belongs to, a χ^2^ goodness-of-fit test was used to test if the distribution of the links is different than 1/3 for each category (p \< 0.05). Each TF is classified using the link category that appears most frequently for that particular TF. The correlation between TFs and genes was measured using a Pearson product-moment correlation coefficient. Only absolute correlations \> 0.9 were considered to be correlated for the following analyses. CoDiNA was computed separately for each day. In order to compare WT and ΔmiR-124 networks, the TFs were distinguished according to category; the names of the genes correlated with the TF were retrieved. The GO enrichment analysis was performed as stated above.

Data and Software Availability {#sec4.6}
------------------------------

The RNA-Seq data discussed in this publication have been deposited in NCBI\'s Gene Expression Omnibus and are accessible through the GEO SuperSeries accession number [GSE118316](ncbi-geo:GSE118316){#intref0225} (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118316>). The wTO tool is available at <https://CRAN.R-project.org/package=wTO> and CoDiNA under <https://CRAN.R-project.org/package=CoDiNA>. Raw counts for RNA-Seq data are also provided in [Tables S7](#mmc4){ref-type="supplementary-material"}, [S10](#mmc7){ref-type="supplementary-material"}, [S12](#mmc9){ref-type="supplementary-material"}, [S13](#mmc10){ref-type="supplementary-material"}, and [S14](#mmc11){ref-type="supplementary-material"}. AGO2 binding signal at the 3' UTR is provided in [Table S8](#mmc5){ref-type="supplementary-material"}. nCounter raw data are listed in [Table S11](#mmc8){ref-type="supplementary-material"}. The high-probability miR-124 target list is provided as [Table S9](#mmc6){ref-type="supplementary-material"}. Luciferase assay raw data are listed in [Table S6](#mmc3){ref-type="supplementary-material"}.
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